Cargando…
Comparing survival functions with interval-censored data in the presence of an intermediate clinical event
BACKGROUND: In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics. METHODS: In the present study, we extend the studies of Finkelstein...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167867/ https://www.ncbi.nlm.nih.gov/pubmed/30285636 http://dx.doi.org/10.1186/s12874-018-0558-y |
_version_ | 1783360276776615936 |
---|---|
author | Kim, Sohee Kim, Jinheum Nam, Chung Mo |
author_facet | Kim, Sohee Kim, Jinheum Nam, Chung Mo |
author_sort | Kim, Sohee |
collection | PubMed |
description | BACKGROUND: In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics. METHODS: In the present study, we extend the studies of Finkelstein and Nam & Zelen to propose new methods for handling interval-censored data with an intermediate clinical event using multiple imputation. The proposed methods consider two types of weights in multiple imputation: 1) uniform weight and 2) the weighted weight methods. RESULTS: Extensive simulation studies were performed to compare the proposed tests with existing methods regarding type I error and power. Our simulation results demonstrate that for all scenarios, our proposed methods exhibit a superior performance compared with the stratified log-rank and the log-rank tests. Data from a randomized clinical study to test the efficacy of sorafenib/sunitinib vs. sunitinib/sorafenib to treat metastatic renal cell carcinoma were analyzed under the proposed methods to illustrate their performance on real data. CONCLUSIONS: In the absence of intensive iterations, our proposed methods show a superior performance compared with the stratified log-rank and the log-rank test regarding type I error and power. |
format | Online Article Text |
id | pubmed-6167867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61678672018-10-09 Comparing survival functions with interval-censored data in the presence of an intermediate clinical event Kim, Sohee Kim, Jinheum Nam, Chung Mo BMC Med Res Methodol Research Article BACKGROUND: In the presence of an intermediate clinical event, the analysis of time-to-event survival data by conventional approaches, such as the log-rank test, can result in biased results due to the length-biased characteristics. METHODS: In the present study, we extend the studies of Finkelstein and Nam & Zelen to propose new methods for handling interval-censored data with an intermediate clinical event using multiple imputation. The proposed methods consider two types of weights in multiple imputation: 1) uniform weight and 2) the weighted weight methods. RESULTS: Extensive simulation studies were performed to compare the proposed tests with existing methods regarding type I error and power. Our simulation results demonstrate that for all scenarios, our proposed methods exhibit a superior performance compared with the stratified log-rank and the log-rank tests. Data from a randomized clinical study to test the efficacy of sorafenib/sunitinib vs. sunitinib/sorafenib to treat metastatic renal cell carcinoma were analyzed under the proposed methods to illustrate their performance on real data. CONCLUSIONS: In the absence of intensive iterations, our proposed methods show a superior performance compared with the stratified log-rank and the log-rank test regarding type I error and power. BioMed Central 2018-10-01 /pmc/articles/PMC6167867/ /pubmed/30285636 http://dx.doi.org/10.1186/s12874-018-0558-y Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Kim, Sohee Kim, Jinheum Nam, Chung Mo Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title | Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title_full | Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title_fullStr | Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title_full_unstemmed | Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title_short | Comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
title_sort | comparing survival functions with interval-censored data in the presence of an intermediate clinical event |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167867/ https://www.ncbi.nlm.nih.gov/pubmed/30285636 http://dx.doi.org/10.1186/s12874-018-0558-y |
work_keys_str_mv | AT kimsohee comparingsurvivalfunctionswithintervalcensoreddatainthepresenceofanintermediateclinicalevent AT kimjinheum comparingsurvivalfunctionswithintervalcensoreddatainthepresenceofanintermediateclinicalevent AT namchungmo comparingsurvivalfunctionswithintervalcensoreddatainthepresenceofanintermediateclinicalevent |